Tirofiban in acute coronary syndromes.

Item

http://www.wikidata.org/entity/Q36107187

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Tirofiban in acute coronary syndromes.

@ast

Tirofiban in acute coronary syndromes.

@en

type

Item

label

Tirofiban in acute coronary syndromes.

@ast

Tirofiban in acute coronary syndromes.

@en

prefLabel

Tirofiban in acute coronary syndromes.

@ast

Tirofiban in acute coronary syndromes.

@en

P1476

Tirofiban in acute coronary syndromes.

@en

P2093

Alberto Menozzi

http://www.w3.org/2001/XMLSchema#string

Diego Ardissino

http://www.w3.org/2001/XMLSchema#string

Piera Angelica Merlini

http://www.w3.org/2001/XMLSchema#string

P2860

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial

Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies

Safety of a high bolus dose of tirofiban in patients undergoing coronary stent placement

Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial

Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE)

P304

193-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.3.2.193

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15853593

http://www.w3.org/2001/XMLSchema#string